MDY - ETF AI Analysis
Top Page
State Street SPDR S&P MidCap 400 ETF Trust (MDY)
MDY’s rating suggests it is a solid mid-cap ETF, supported by several strong holdings with healthy financial performance and positive growth outlooks. Standouts like TechnipFMC, United Therapeutics, and ATI contribute positively through robust earnings, bullish trends, and strategic initiatives, while some positions such as Entegris and nVent Electric introduce caution due to valuation concerns and weaker technical momentum. The main risk factor is that many top holdings face valuation or technical pressures, which could increase volatility even though the overall portfolio remains broadly diversified across companies.
MDY vs. SPDR S&P 500 ETF (SPY)
- AUM
- 26.10B
- Region
- North America
- Expense Ratio
- 0.23%
- Beta
- 0.89
- Issuer
- SPDR
- Inception Date
- May 04, 1995
- Dividend Yield
- 1.04%
- Asset Class
- Equity
- Index Tracked
- S&P Mid Cap 400
MDY Summary
MDY is an ETF that follows the S&P MidCap 400 Index, which focuses on medium-sized U.S. companies across many industries, including industrials, technology, and health care. It gives investors a simple way to invest in a broad mix of mid-sized businesses that may offer a balance of growth and stability. Well-known holdings include Okta and Roku. Someone might invest in MDY to diversify their portfolio beyond just large, well-known companies and tap into the growth potential of mid-cap stocks. A key risk is that the value of the ETF can go up and down with the overall stock market.
How much will it cost me?
This ETF has an expense ratio of 0.23%, which means you’ll pay about $2.30 per year for every $1,000 invested. That’s slightly higher than the cheapest index ETFs, but still reasonable, and it reflects that you’re getting a more specialized, passively managed fund focused on mid-cap stocks.
What would affect this ETF?
MDY could benefit if the U.S. economy continues to grow, since mid-sized industrial, technology, and consumer-focused companies often see profits rise as business investment and consumer spending increase, and its broad sector mix helps spread risk. On the downside, higher interest rates, an economic slowdown in the U.S., or tighter regulations affecting areas like health care, financials, or technology could hurt earnings for its top holdings and weigh on the fund’s overall performance.
MDY Top 10 Holdings
MDY is powered by a diverse cast of U.S. mid-cap names, with a noticeable tilt toward industrials, energy, and health care. Permian Resources has been a key engine, riding strong energy momentum, while Okta and Entegris add tech flair with rising, if sometimes volatile, performance. United Therapeutics and Tenet Healthcare provide steady health care ballast, helping smooth out bumps. On the flip side, nVent Electric and ATI have been losing a bit of steam lately, modestly dragging on returns. Overall, the fund’s broad mid-cap mix keeps any single laggard from steering the ship off course.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 OKTA | Okta | 0.90% | $236.66M | $32.32B | 108.26% | 75Outperform |
 FTI | TechnipFMC | 0.75% | $196.58M | $26.00B | 58.53% | 80Outperform |
 UTHR | United Therapeutics | 0.74% | $193.71M | $25.57B | 37.08% | 79Outperform |
 ATI | ATI | 0.70% | $184.43M | $23.68B | 82.87% | 78Outperform |
 ENTG | Entegris | 0.67% | $175.31M | $23.16B | 67.17% | 66Neutral |
 USFD | US Foods Holding | 0.63% | $164.69M | $22.89B | 37.53% | 74Outperform |
 RS | Reliance Steel | 0.65% | $170.20M | $22.83B | 57.76% | 74Outperform |
 XPO | XPO | 0.64% | $168.10M | $22.34B | 38.22% | 70Outperform |
 THC | Tenet Healthcare | 0.62% | $161.28M | $21.40B | 32.42% | 74Outperform |
 PR | Permian Resources | 0.58% | $150.98M | $20.57B | 90.33% | 81Outperform |
MDY Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MDY, the sentiment is Positive. The current price of 676.25 is above the 20-day moving average (MA) of 666.99, above the 50-day MA of 671.67, and above the 200-day MA of 664.06, indicating a bullish trend. The MACD of 0.60 indicates Negative momentum. The RSI at 56.07 is Neutral, neither overbought nor oversold. The STOCH value of 69.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MDY.
MDY Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| MDY | $676.25 | $737.00(8.98% Upside) | $26.10B | 0.23% | 70Outperform |
 IJH | $74.13 | $91.61(23.58% Upside) | $124.27B | 0.05% | 73Outperform |
 VO | $81.67 | $98.62(20.76% Upside) | $107.68B | 0.03% | 69Neutral |
 IWR | $110.35 | $131.41(19.09% Upside) | $58.16B | 0.18% | 68Neutral |
 SPMD | $64.95 | $79.62(22.58% Upside) | $18.68B | 0.03% | 71Outperform |
 IVOO | $125.39 | $156.73(24.99% Upside) | $3.93B | 0.07% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MDY | State Street SPDR S&P MidCap 400 ETF Trust | 676.25 | 91.26 | 15.60% | |
| IJH | iShares Core S&P Mid-Cap ETF | 74.13 | 10.18 | 15.91% | |
| VO | Vanguard Mid-Cap ETF | 81.67 | 10.57 | 14.87% | |
| IWR | iShares Russell Midcap ETF | 110.35 | 16.36 | 17.41% | |
| SPMD | SPDR Portfolio S&P 400 Mid Cap ETF | 64.95 | 8.94 | 15.96% | |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 125.39 | 17.14 | 15.83% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.